Vimarsana
Biggest News Aggregation in the World

Cancer Research Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cancer Research Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cancer Research Programme Today - Breaking & Trending Today

RT News February 11, 2018 - Vimarsana News

RT News February 11, 2018

I welcome his weekly with me kevin zero in here on r t r round up and big stories of the last seven days thanks for your time and taking that watches first in the Winter Olympics in south korea got underway on friday with a grand Opening Ceremony in the host city pyong chang nearly three thousand athletes from ninety two countries took part in the event however in the run up to the celebrations there were demonstrations and scuffles outside the Olympic Arena people supporting peace between north and south korea had gathered for a rally while another Group Protesting north koreas participation ...

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance - Vimarsana News

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

New approach radically increases the success of breast cancer immunotherapy - Vimarsana News

New approach radically increases the success of breast cancer immunotherapy

A study published in the journal Nature Cancer, carried out within the Cancer Programme at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, led by Dr. Toni Celià-Terrassa, and the Laboratory of Molecular Cancer Therapy, coordinated by Dr. Joan Albanell, with the participation of international centers, has discovered an approach that radically increases the success of immunotherapy in one of the most aggressive types of tumors, triple-negative breast cancer.